PRAC: Selexipag Under Review, Starts Antibiotic Safety Review PRAC: Selexipag Under Review, Starts Antibiotic Safety Review

PRAC advises continued use of selexipag (Uptravi), on the basis of preliminary data review; launches review of long-lasting side effects with quinolone and fluoroquinolone antibiotics.News Alerts
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Pulmonary Medicine News Alert Source Type: news